1. Stocks
  2. Quoin Pharmaceuticals Ltd - ADR
  3. Swot
swot-logo

Quoin Pharmaceuticals Ltd - ADR SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Quoin Pharmaceuticals Ltd - ADR has 13 Strengths, 9 Weaknesses, 1 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Positive Breakout First Resistance ( LTP > R1)

Rising Net Cash Flow and Cash from Operating activity

Stocks whose current price is 20% higher than week low, and more than previous close

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Positive Breakout (LTP > R1)

Top Gainers

Stock with Low PE (PE < = 10)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Highest fall from 52 Week High

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

Stocks Underperforming their Industry Price Change in the Quarter

Institutions increasing their shareholding